Loading…
Held by equity mutual funds in 112 disclosed months, Jun 2017 to Sep 2026.
Eris Lifesciences Limited (Pharmaceuticals & Biotechnology) was held by 26 active equity mutual funds in September 2026, ₹1,949 Cr in all (up 0 funds from Aug 2026). The largest position was Bank of India Consumption Fund at 2.6% of its portfolio. During the month 3 funds entered and 3 exited. Funds have disclosed holding it since Jun 2017.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.
None.